n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)
4 Stocks Rising on Big Volume

4 Stocks Rising on Big Volume

Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far

It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far

Here are some random thoughts and observations from what I saw and heard this morning. Totally off the cuff stuff on Celgene, InterMune, Alnylam, NPS Pharma and Seattle Genetics.

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Tekmira Pharmaceuticals Enters Oversold Territory (TKMR)

Tekmira Pharmaceuticals Enters Oversold Territory (TKMR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tekmira Provides Corporate Update And Announces Third Quarter 2013 Results

Tekmira Provides Corporate Update And Announces Third Quarter 2013 Results

Conference Call at 4:30 pm Eastern Time Today

Ratings Changes Today

Upgrades: ACM, BZH, DECK, KT, PPP, RMTI, TKMR Downgrades: AMED, COR, ESC, INWK, IRBT, MGPI, MX, NL, OPLK, PERI, RMCF, RRMS, SYPR, UNAM, VNR Initiations: SHOS Read on to get TheStreet Quant Ratings' detailed report:

Tekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02)

Tekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02)

Phase II Data Presented at Scientific Symposium Further Validates Tekmira's LNP Technology

Another Fine Day for the Bulls

The trend to the upside remains quite strong.